PRMT1 and colorectal carcinoma: Two clinical reports demonstrated the unfavorable prognosis associated with PRMT1 expression in colorectal cancer (CRC) patients by discussing the respective involvement of PRMT1-v1 and PRMT-v2 isoforms [154,155].